Aspire Biopharma: Funding, Investors & Team (Nov 2026)
Aspire Biopharma is a biotechnology company specializing in nanotechnology-based drug formulation and the development of medicinal products. The company focuses on enhancing drug delivery systems to improve bioavailability and therapeutic effectiveness. Its research and development efforts aim to advance pharmaceutical solutions across various therapeutic areas.
Aspire Biopharma has raised $22.5M across 1 funding round on record, the most recent an undisclosed round of $22.5M announced in Apr 2026.
That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aspire Biopharma Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Aspire Biopharma Funding Rounds
Aspire Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Aspire Biopharma Funding Compared to Other Biotechnology Startups
Aspire Biopharma's latest round of $22.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aspire Biopharma in Biotechnology and San Juan
Companies Similar to Aspire Biopharma
Island (ASX: ILA) is a drug repurposing company, focused on the rapid development of antiviral therapeutics…
Orakl Oncology is dedicated to accelerating drug discovery in oncology using advanced biology and AI-powered…
Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…
VectorY utilizes a combination of antibodies and gene therapy to create effective and long-lasting treatments…
Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.
Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…
Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…
It is our mission to open a new chapter in treating diseases and to deliver so called selectively expressed…
altM's goal is to create and produce scalable biomaterials that can assist major industries in decreasing…
The Company's corporate purpose is: I) the development of new high-value biotechnological solutions based on…
Venomics AI is a drug discovery platform using venom peptides for therapeutics.
Aspire Biopharma Funding FAQs
What does Aspire Biopharma do?
Aspire Biopharma is a biotechnology company specializing in nanotechnology-based drug formulation and the development of medicinal products. The company focuses on enhancing drug delivery systems to improve bioavailability and therapeutic effectiveness. Its research and development efforts aim to advance pharmaceutical solutions across various therapeutic areas.
How much funding has Aspire Biopharma raised?
Aspire Biopharma has raised $22.5M across 1 round on record. The most recent is an undisclosed round of $22.5M announced in Apr 2026.
When did Aspire Biopharma last raise funding?
Aspire Biopharma's most recent funding round on record is an undisclosed round of $22.5M, announced in Apr 2026.
Who founded Aspire Biopharma?
FundedIQ lists Lance B (Founder) at Aspire Biopharma.
Where is Aspire Biopharma headquartered?
Aspire Biopharma is based in San Juan, NA - Puerto Rico, Puerto Rico.
How many employees does Aspire Biopharma have?
Aspire Biopharma is in the 11-50 employee band.
How does Aspire Biopharma's funding compare to other Biotechnology startups?
Aspire Biopharma's latest round of $22.5M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's Aspire Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aspire Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.